Top Stock Picks Portfolio Comments
2018-07-16: Watch List candidate **** triggered it's buy point, and was purchased for the GSA Portfolio.
Current Stock Portfolio Positions: CH** (+6%), OP** (+6%), US** (+4%), FN** (+1%), RS** (+1%), FI** (+1%), MR** (-4%),
| || |
Past Top Stock Pick Learn from these chart patterns. (Past performance does not guarantee future results)
Up 25% from $116.95 (2012-01-13)
On January 13, 2012 we profiled Biogen Idec Inc (BIIB) as a Top Stock Pick
to our members at $116.95. Within a period of six months, BIIB rose to a high of $145.73, for a return at it's peak of 25%. Obviously, one cannot sell exactly at the peak, but here is what we had observed about BIIB:
- GSA Rank: 60.54 (Our proprietary ranking for BIIB using fundamental AND technical factors)
- Accum/Dist Rank: 1.23 (Up vs. down volume action of BIIB taken over several weeks)
- Industry Group Rank: 20 (BIIB was in an industry showing strong group action)
- Projected Growth Rate: 11.70% (BIIB's projected 5-year growth rate)
Most importantly, BIIB was trading just 3.6% off it's 52-week high price, and had a breakout from a sideways price consolidation pattern, a clear signal to time our position. It is imperative to not only buy the best stocks that are fundamentally sound, but also to time your purchase correctly.